Details for 2017730628

Up to date per 04.04.2026

Actions

Title / Product Name

KOMBINIERTE VERWENDUNG VON MARIZOMIB UND BEVACIZUMAB ZUR BEHANDLUNG VON KREBS DES ZENTRALEN NERVENSYSTEMS (ZNS)

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017730628

EP Publication Number

3463458

E-Number

1674223

Language

PCT Number

US17035504

Publication Date

10.04.2019 A

10.04.2024 B1

Registration Date

10.04.2024

AT Publication Date

15.04.2024

Application Date

01.06.2017

Registration Number

Priorities

01.06.2016

201662344194 P

13.06.2016

201662349491 P

15.07.2016

201662362845 P

12.08.2016

201662374136 P

07.11.2016

201662418466 P

18.11.2016

201662424178 P

14.03.2017

201762471321 P

26.04.2017

201762490528 P

28.04.2017

201762491943 P

IPC

A61K 39/395 20060101AFI20171208BHEP

Maximum Duration of Protection

01.06.2037

Owner

Celgene Tri A Holdings Ltd.Aon House 30 Woodbourne Avenue Pembroke HM 08BM

Trikha, Mohit3366 N. Torrey Pines Court 210 La Jolla, California 92037US

Levin, Nancy3366 N. Torrey Pines Court 210 La Jolla, California 92037US

Maclaren, Ann3366 N. Torrey Pines Court 210 La Jolla, California 92037US

Representative

No representatives present

Inventor

TRIKHA, Mohit3366 N. Torrey Pines Court 210 La Jolla California 92037US

LEVIN, Nancy3366 N. Torrey Pines Court 210 La Jolla California 92037US

MACLAREN, Ann3366 N. Torrey Pines Court 210 La Jolla California 92037US